Drug Profile
YKP 10A
Alternative Names: R 228060; YKP10ALatest Information Update: 29 Sep 2011
Price :
$50
*
At a glance
- Originator SK Bio-Pharmaceuticals; SK Corporation
- Developer Janssen; SK biopharmaceuticals; SK Holdings
- Class Antidepressants; Sleep disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported CNS disorders; Major depressive disorder; Narcolepsy; Neuropathic pain
Most Recent Events
- 29 Sep 2011 No development reported - Preclinical for CNS disorders in USA (PO)
- 29 Sep 2011 No development reported - Preclinical for Narcolepsy in USA (PO)
- 29 Sep 2011 No development reported - Preclinical for Neuropathic pain in USA (PO)